Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluating and Mitigating the Immunogenicity of Therapeutic Proteins
Zuben E. Sauna, Daniel Lagassé, João Pedras-Vasconcelos, et al.
Trends in biotechnology (2018) Vol. 36, Iss. 10, pp. 1068-1084
Closed Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

The Role of Ligands in the Chemical Synthesis and Applications of Inorganic Nanoparticles
Amelie Heuer‐Jungemann, Neus Feliu, Ioanna Bakaimi, et al.
Chemical Reviews (2019) Vol. 119, Iss. 8, pp. 4819-4880
Open Access | Times Cited: 933
T Cell Epitope Predictions
Bjoern Peters, Morten Nielsen, Alessandro Sette
Annual Review of Immunology (2020) Vol. 38, Iss. 1, pp. 123-145
Open Access | Times Cited: 212
Subcutaneous delivery of monoclonal antibodies: How do we get there?
Margarida Viola, Joana A.D. Sequeira, Raquel Seiça, et al.
Journal of Controlled Release (2018) Vol. 286, pp. 301-314
Closed Access | Times Cited: 179
Protein Nanoparticles: Uniting the Power of Proteins with Engineering Design Approaches
Nahal Habibi, Ava Mauser, Yeongun Ko, et al.
Advanced Science (2022) Vol. 9, Iss. 8
Open Access | Times Cited: 72
Mechanisms and Barriers in Nanomedicine: Progress in the Field and Future Directions
Thomas J. Anchordoquy, Natalie Artzi, Irina V. Balyasnikova, et al.
ACS Nano (2024) Vol. 18, Iss. 22, pp. 13983-13999
Closed Access | Times Cited: 21
Advances in Synthetic Immunology for Targeted Treatment of Systemic Autoimmune Diseases: Opportunities, Challenges, and Future Directions
Galih Januar Adytia, Henry Sutanto, Laras Pratiwi, et al.
Immuno (2025) Vol. 5, Iss. 1, pp. 6-6
Open Access | Times Cited: 1
Accelerating the development of novel technologies and tools for the subcutaneous delivery of biotherapeutics
David S. Collins, Manuel Sánchez-Félix, Advait Badkar, et al.
Journal of Controlled Release (2020) Vol. 321, pp. 475-482
Open Access | Times Cited: 86
Science and art of protein formulation development
Wei Wang, Satoshi Ohtake
International Journal of Pharmaceutics (2019) Vol. 568, pp. 118505-118505
Closed Access | Times Cited: 84
Derivatization with fatty acids in peptide and protein drug discovery
Peter Kurtzhals, Søren Østergaard, Erica Nishimura, et al.
Nature Reviews Drug Discovery (2022) Vol. 22, Iss. 1, pp. 59-80
Closed Access | Times Cited: 67
Stabilization challenges and aggregation in protein-based therapeutics in the pharmaceutical industry
Mahdie Rahban, Faizan Ahmad, Mieczyslaw A. Piatyszek, et al.
RSC Advances (2023) Vol. 13, Iss. 51, pp. 35947-35963
Open Access | Times Cited: 31
Therapeutic proteins: developments, progress, challenges, and future perspectives
Vimal Kumar, Arti Barwal, Nitin Sharma, et al.
3 Biotech (2024) Vol. 14, Iss. 4
Closed Access | Times Cited: 9
Restraining the power of Proteolysis Targeting Chimeras in the cage: A necessary and important refinement for therapeutic safety
Renshuai Zhang, Songbo Xie, Jie Ran, et al.
Journal of Cellular Physiology (2024) Vol. 239, Iss. 5
Closed Access | Times Cited: 9
Structure-based Methods for Binding Mode and Binding Affinity Prediction for Peptide-MHC Complexes
Dinler A. Antunes, Jayvee R. Abella, Didier Devaurs, et al.
Current Topics in Medicinal Chemistry (2019) Vol. 18, Iss. 26, pp. 2239-2255
Open Access | Times Cited: 69
Toward Drug-Like Multispecific Antibodies by Design
Manali Sawant, Craig Streu, Lina Wu, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7496-7496
Open Access | Times Cited: 50
Growth Factor and Cytokine Delivery Systems for Wound Healing
Julien M. D. Legrand, Mikaël M. Martino
Cold Spring Harbor Perspectives in Biology (2022) Vol. 14, Iss. 8, pp. a041234-a041234
Open Access | Times Cited: 36
Accelerating therapeutic protein design with computational approaches toward the clinical stage
Zhidong Chen, Xinpei Wang, Xu Chen, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 2909-2926
Open Access | Times Cited: 21
Multivalent protein-drug conjugates – An emerging strategy for the upgraded precision and efficiency of drug delivery to cancer cells
Natalia Porębska, Krzysztof Ciura, Aleksandra Chorążewska, et al.
Biotechnology Advances (2023) Vol. 67, pp. 108213-108213
Open Access | Times Cited: 17
Defining ortholog-specific UHRF1 inhibition by STELLA for cancer therapy
Wenjing Bai, Jinxin Xu, Wenbin Gu, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Development of ImmTOR Tolerogenic Nanoparticles for the Mitigation of Anti-drug Antibodies
Takashi Kishimoto
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 48
First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist, in Combination with Rituximab in Patients with Follicular and Other CD20+ Non-Hodgkin Lymphomas
Ajay K. Gopal, Ronald Levy, Roch Houot, et al.
Clinical Cancer Research (2020) Vol. 26, Iss. 11, pp. 2524-2534
Open Access | Times Cited: 47
The past, present, and future of enzyme-based therapies
Jennifer N. Hennigan, Michael Lynch
Drug Discovery Today (2021) Vol. 27, Iss. 1, pp. 117-133
Open Access | Times Cited: 33
Engineering and evaluation of FXa bypassing agents that restore hemostasis following Apixaban associated bleeding
Wojciech Jankowski, Stepan S. Surov, Nancy Hernandez, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Anti-Drug Antibody Response to Therapeutic Antibodies and Potential Mitigation Strategies
Erin L. Howard, Melanie M. Goens, Leonardo Susta, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 299-299
Open Access
Highly Variable Aggregation and Glycosylation Profiles and Their Roles in Immunogenicity to Protein-Based Therapeutics
Sina Sarsarshahi, Sanghati Bhattacharya, Zeb R. Zacharias, et al.
Journal of Pharmaceutical Sciences (2025), pp. 103771-103771
Closed Access
Resources and computational strategies to advance small molecule SARS-CoV-2 discovery: Lessons from the pandemic and preparing for future health crises
Natesh Singh, Bruno O. Villoutreix
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 2537-2548
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top